Apatinib for Metastatic Esophageal Cancer.

Clinical trial NCT02544737 · UNKNOWN

Trial details

NCT number: NCT02544737
Sponsor: Hangzhou Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Metastatic Esophageal Cancer Apatinib

Start date: 2015-09-01
Primary completion: 2016-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.